At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 35 enrolled
Drug / intervention
Vancomycin +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
In Brief
A Phase 1 clinical trial evaluating Vancomycin and Metronidazole for Primary Sclerosing Cholangitis. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether Vancomycin or Metronidazole is safe and beneficial in the treatment of Primary Sclerosing Cholangitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Sclerosing Cholangitis
CountriesUnited States
CollaboratorsPSC Partners Seeking a Cure
Timeline
Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
First PostedMar 2010
Primary CompletionNov 2011
TodayJul 2026
First PostedMar 12, 2010
Enrollment StartFeb 1, 2010
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.3 years ago
Interventions
Vancomycindrug
Comparison of different doses of drug
Vancomycindrug
Comparison of different doses of drug
Metronidazoledrug
Comparison of different doses of drug
Metronidazoledrug
Comparison of different doses of drug
Vancomycindrug
Comparison of different drug doses